ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,497,463, issued on Dec. 16, was assigned to JIANGSU KANION PHARMACEUTICAL Co. LTD. (Jiangsu, China).
"Anti-CD38 antibody and use thereof" was invented by Wei Xiao (Jiangsu, China), Aizhi Zhao (Wallingford, Pa.), Yueheng Han (Wallingford, Pa.), Zhenzhong Wang (Jiangsu, China), Chenfeng Zhang (Jiangsu, China), Liang Cao (Jiangsu, China), Jianming Zhou (Jiangsu, China) and Liang Li (Jiangsu, China).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are a composition containing a CD38 antibody or a fragment thereof, and a use of the composition in treating diseases associated with CD38 expression."
The patent was filed on June 22, 2021, under Applicati...